(Q40315570)

19 September 2017

Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells (English)

1 reference

19 September 2017

0 references

Stachler MD

1

1 reference

19 September 2017

Bartlett JS

series ordinal

2

1 reference

19 September 2017

1 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

11

1 reference

19 September 2017

926-931

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302738

19 September 2017

0 references

cites work

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Selective and rapid uptake of adeno-associated virus type 2 in brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Serum-free production and column purification of adeno-associated virus type 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Altering AAV tropism with mosaic viral capsids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302738

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302738

1 reference

Dimensions Publication ID

19 September 2017

1043583248

0 references

Fatcat ID

release_p7gediyz5ncrhd5z3u4e6xw3nu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7gediyz5ncrhd5z3u4e6xw3nu

24 November 2022

mapped directly with Wikidata item

1 reference